As a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
Explore career opportunities at Roche, a global leader in healthcare innovation and diagnostics, and join their mission to improve lives worldwide.
About Roche Since our founding over 125 years ago, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas. Our commitment to our people, partners, stakeholders and, most importantly, our patients remains as strong as it was on the first day ...
Roche Pharmaceuticals is focused on translating excellence in science into effective medicines for patients. It combines cutting-edge research at Roche, Genentech, in the US Chugai in Japan and over 250 partners worldwide with global scale and reach in clinical development, manufacturing and commercial operations.
Roche was founded in Basel, Switzerland in 1896 as one of the first manufacturers of branded medicines. Today, we are the world’s largest biotechnology company and the global leader in in-vitro diagnostics, dedicated to tackling healthcare challenges that place the greatest strain on patients, families, communities and healthcare systems.
Our contact directory for Roche operations around the world can be found on our locations page. Our digital presence spans Roche.com and dedicated regional sites across 70+ countries. Discover how our integrated platforms connect patients, healthcare professionals, and innovators to advance personalized healthcare solutions and shape the future of medicine through seamless collaboration and ...
The new computational infrastructure supports Roche’s vision of building an AI-accelerated healthcare organisation. NVIDIA AI factories help accelerate discoveries, enable more efficient clinical trials, and unlock data insights at scale, ultimately advancing innovation and improved healthcare outcomes.
Roche launches NVIDIA AI factory to accelerate the development of new ...
Roche has published its Full Year Results for 2025 prior to the opening of the Swiss Stock Exchange on Thursday, 29 January 2026.
This page provides details of all Roche worldwide locations. If you would like to get in touch with us for different types of queries relating to our medications, diagnostic products and Roche services please visit the contact us page. If you have questions about one of our Pharma products or would like to raise a potential product quality concern or to report a potential side effect, please ...
Reuters on MSN: Roche submits multiple sclerosis drug fenebrutinib to regulators despite patient deaths
By Marleen Kaesebier and Patricia Weiss ZURICH, April 22 (Reuters) - Swiss drugmaker Roche on Wednesday said it was submitting its experimental multiple sclerosis drug fenebrutinib to global ...
Fierce Biotech: Roche unpacks death imbalance, secondary endpoints in phase 3 multiple sclerosis trials
Roche has shared details of fatalities in its phase 3 relapsing multiple sclerosis (RMS) trials, revealing that deaths from infections, diabetes complications and an accident contributed to an ...
Roche unpacks death imbalance, secondary endpoints in phase 3 multiple sclerosis trials
Zacks Investment Research on MSN: Roche highlights Gazyva progress, reports data on Enspryng, MS drug
Roche RHHBY announced that the FDA has accepted its supplemental application for Gazyva/Gazyvaro (obinutuzumab) to treat systemic lupus erythematosus (SLE), based on strong phase III ALLEGORY study ...
Fierce Pharma: Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy
Roche is launching a new global phase 3 trial for the controversial Duchenne muscular dystrophy gene therapy Elevidys in another push for European approval. | Rather than relying on patient groups to ...
Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy
Roche and Johnson & Johnson have unveiled pivotal late-stage results for therapies targeting challenging autoimmune diseases, showing significant clinical benefits and strong safety profiles. Roche’s ...
FiercePharma: UPDATE: Roche overhauls Spark gene therapy unit, recording $2.4B in full impairment
Roche has recently launched a “fundamental reorganization” of Spark Therapeutics, the gene therapy unit the Swiss pharma bought for $4.3 billion in 2019. Roche described the restructuring in its ...
UPDATE: Roche overhauls Spark gene therapy unit, recording $2.4B in full impairment
FierceBiotech: Roche, pipeline bulging from deal spree, axes 8 oncology and neurology programs to speed up R&D
Roche has removed eight phase 1 and 2 oncology and neurology candidates from its pipeline as part of a set of “trade-offs” intended to “increase the overall portfolio value and speed up development.” ...
Roche, pipeline bulging from deal spree, axes 8 oncology and neurology programs to speed up R&D
Seeking Alpha: Roche: Sustainable Sales Growth, Margin Leverage, And Supportive Late-Stage Pipeline
Q4 results reinforce our positive outlook on Roche, highlighting the company's resilience and strategic advancements. Solid performance of Ocrevus and Vabysmo are key drivers of near-term top-line ...
Roche has agreed to acquire Telavant Holdings for up to $7.25 billion, in a deal designed to bolster the buyer’s pipeline with an inflammatory bowel disease candidate that could potentially also be ...
Seeking Alpha: Roche Is The 'Value Play' Of The 2026 Obesity Gold Rush
Roche remains a Buy, driven by strong pipeline progress and conservative valuation, with shares up 36% since my last recommendation. CT388-103's Phase 2 obesity data show placebo-adjusted weight loss ...
The Indianapolis Star: Roche will put $550 million facility for glucose monitors in Indianapolis, adding 650 jobs
Roche Diagnostics will invest $550 million in its Indianapolis base to construct a new manufacturing facility for glucose monitoring devices, which will add several hundred jobs and further solidify ...
Roche will put $550 million facility for glucose monitors in Indianapolis, adding 650 jobs
The rain brought some relief from this heat. The explosion brought the building crashing to the ground. What brings you here? Prosecutors brought charges against the program’s director. Funding cuts brought an end to the project. Wicks brought her to the attention of a movie producer.
Define brings. brings synonyms, brings pronunciation, brings translation, English dictionary definition of brings. to carry, convey, or conduct: I will bring my friend with me when I come.
When you are talking, you can say that something brings you to a particular point in order to indicate that you have now reached that point and are going to talk about a new subject.